Although this difference approached but did not reach the threshold for clinical significance established in other studies, 134 the findings suggest the potential neuroprotective effects of lixisenatide, possibly mediated by increased synaptic dopamine levels, as supported by preclinical and clinical research in addictive disorders
Check your formulary proactively rather than finding out at the pharmacy counter
Prior authorization denials are common, approval timelines can stretch weeks, and many plans exclude GLP-1 medications from their weight loss formulary
The FDA is also monitoring the availability of other GLP-1 medications, including dulaglutide and liraglutide, which remain in shortage.) (UPDATE 10/14/24: In a court filing on the 11th the FDA stated they would allow compounding pharmacies to continue to produce compounded tirzepatide medications while it reviewed whether there was a shortage of the active ingredient
GLP-1 works by slowing down your stomachs emptying process and reducing hunger signals to your brain, while GIP helps with fat metabolism and insulin sensitivity